NVSEF

NOVARTIS AG BASEL AKT by Novartis AG (NVSEF)

About NOVARTIS AG BASEL AKT by Novartis AG (NVSEF)

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Details

Daily high
$155.26
Daily low
$152.77
Price at open
--
52 Week High
$155.26
52 Week Low
$97.30
Market cap
291.5B
Dividend yield
2.60%
Volume
5,504
Avg. volume
191,535
P/E ratio
21.20

NOVARTIS AG BASEL AKT by Novartis AG News

Details

Daily high
$155.26
Daily low
$152.77
Price at open
--
52 Week High
$155.26
52 Week Low
$97.30
Market cap
291.5B
Dividend yield
2.60%
Volume
5,504
Avg. volume
191,535
P/E ratio
21.20